News
An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.
Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...
From natural stone countertops to well-made furniture, here are the timeless decorating decisions you'll never regret, according to interior designers.
Final results from an Investigator-Initiated Trial presented for the first time, demonstrating favorable safety, significant target engagement, and encouraging clinical & biomarker signals Abstract ...
The largest survey yet to examine seriously ill patients receiving charitable copayment assistance found high out-of-pocket costs impact access to health care, adherence to medication, and quality of ...
In the aftermath of identity theft, taking swift action is crucial to minimizing damage and preventing further fraud. Console & Associates, P.C., a data breach class action law firm, offers guidance ...
14d
Zacks Investment Research on MSNPromising Genomics & Synthetic Biology Stocks to Consider in 2025Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary ...
Eli Lilly's next Phase III trial is assessing whether lepodisiran can not only reduce levels of lipoprotein(a) but also ...
The extracellular matrix glycosaminoglycan hyaluronic acid (HA) is the principle ligand of CD44 ... Knockdown of CD44v6 with siRNA in DU145, PC3M, and LNCaP cells increased sensitivity to doxorubicin, ...
The data convincingly show that the transcription factor Sp1 regulates ephrin-mediated axon guidance in the spinal cord. Although the authors show that Sp1 and its co-activators p300 and CBP are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results